Literature DB >> 22332030

Interstitial Lung Disease in Children Older Than 2 Years.

Timothy J Vece1, Leland L Fan.   

Abstract

The spectrum of childhood interstitial lung diseases (chILD) encompasses a group of heterogeneous, rare disorders in children characterized by diffuse pulmonary infiltrates and disordered gas exchange. Whereas the disorders that present in early life are unique to children, those that present in older children are also seen in adults. This review will concentrate on chILD presenting in children older than 2 years of age with a focus on the idiopathic interstitial pneumonias, connective tissue diseases, alveolar hemorrhage, and hypersensitivity pneumonitis. A systematic approach to diagnosis that includes a careful history and physical, computed tomography of the chest, bronchoalveolar lavage, and lung biopsy can be very helpful in establishing the correct diagnosis. Treatment approaches are described, including general supportive measures, indications for a trial of systemic corticosteroids, or other immunomodulating therapies, and when lung transplantation reserved for those with end-stage lung disease should be considered.

Entities:  

Year:  2010        PMID: 22332030      PMCID: PMC3269221          DOI: 10.1089/ped.2010.0008

Source DB:  PubMed          Journal:  Pediatr Allergy Immunol Pulmonol        ISSN: 2151-321X            Impact factor:   1.349


  55 in total

Review 1.  Pulmonary complications of connective tissue diseases.

Authors:  Felix Woodhead; Athol U Wells; Sujal R Desai
Journal:  Clin Chest Med       Date:  2008-03       Impact factor: 2.878

2.  Treatment of pulmonary hemangiomatosis with recombinant interferon alfa-2a.

Authors:  C W White; H M Sondheimer; E C Crouch; H Wilson; L L Fan
Journal:  N Engl J Med       Date:  1989-05-04       Impact factor: 91.245

3.  Systemic sclerosis: using high-resolution CT to detect lung disease in children.

Authors:  J M Seely; L T Jones; C Wallace; D Sherry; E L Effmann
Journal:  AJR Am J Roentgenol       Date:  1998-03       Impact factor: 3.959

4.  Interstitial lung disease associated with juvenile dermatomyositis: clinical features and efficacy of cyclosporin A.

Authors:  I Kobayashi; M Yamada; Y Takahashi; N Kawamura; M Okano; Y Sakiyama; K Kobayashi
Journal:  Rheumatology (Oxford)       Date:  2003-02       Impact factor: 7.580

5.  Childhood hypersensitivity pneumonitis probably caused by cat hair.

Authors:  H V Olesen; T Thelle; J C Møller
Journal:  Acta Paediatr       Date:  1998-07       Impact factor: 2.299

6.  EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR).

Authors:  O Kowal-Bielecka; R Landewé; J Avouac; S Chwiesko; I Miniati; L Czirjak; P Clements; C Denton; D Farge; K Fligelstone; I Földvari; D E Furst; U Müller-Ladner; J Seibold; R M Silver; K Takehara; B Garay Toth; A Tyndall; G Valentini; F van den Hoogen; F Wigley; F Zulian; Marco Matucci-Cerinic
Journal:  Ann Rheum Dis       Date:  2009-01-15       Impact factor: 19.103

7.  Upregulation of Th1 cytokine profile in bronchoalveolar lavage fluid of patients with hypersensitivity pneumonitis.

Authors:  R M Mroz; M Korniluk; A Stasiak-Barmuta; E Chyczewska
Journal:  J Physiol Pharmacol       Date:  2008-12       Impact factor: 3.011

8.  Azathioprine or methotrexate maintenance for ANCA-associated vasculitis.

Authors:  Christian Pagnoux; Alfred Mahr; Mohamed A Hamidou; Jean-Jacques Boffa; Marc Ruivard; Jean-Pierre Ducroix; Xavier Kyndt; François Lifermann; Thomas Papo; Marc Lambert; José Le Noach; Mehdi Khellaf; Dominique Merrien; Xavier Puéchal; Stéphane Vinzio; Pascal Cohen; Luc Mouthon; Jean-François Cordier; Loïc Guillevin
Journal:  N Engl J Med       Date:  2008-12-25       Impact factor: 91.245

9.  Maintenance therapy with dose-adjusted 6-mercaptopurine in idiopathic pulmonary hemosiderosis.

Authors:  Xue-Qun Luo; Zhi-Yong Ke; Li-Bin Huang; Xiao-Qing Guan; Xiao-Li Zhang; Jia Zhu; Ying-Chuang Zhang
Journal:  Pediatr Pulmonol       Date:  2008-11

Review 10.  Pulmonary haemosiderosis in infants and children.

Authors:  Thomas G Nuesslein; Norbert Teig; Christian H L Rieger
Journal:  Paediatr Respir Rev       Date:  2006-01-30       Impact factor: 2.726

View more
  8 in total

1.  Expanding Our Understanding of Children's Interstitial Lung Disease.

Authors:  Robin R Deterding
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2010-03       Impact factor: 1.349

2.  Nonspecific Interstitial Pneumonitis in a Child Associated With Hashimoto Thyroiditis.

Authors:  Sinan Yavuz; Doha Mouner; Gangaiah Komala; Ahmed Albarkouky; Mohamed Roshan; Nader Francis
Journal:  Cureus       Date:  2022-06-18

3.  Idiopathic desquamative interstitial pneumonia in a child: a case report.

Authors:  Sabrina Bressieux-Degueldre; Samuel Rotman; Gaudenz Hafen; John-David Aubert; Isabelle Rochat
Journal:  BMC Res Notes       Date:  2014-06-22

Review 4.  Why is a paediatric respiratory specialist integral to the paediatric rheumatology clinic?

Authors:  Manisha Ramphul; Kathy Gallagher; Kishore Warrier; Sumit Jagani; Jayesh Mahendra Bhatt
Journal:  Breathe (Sheff)       Date:  2020-12

5.  COVID-19 Like Findings in a Fatal Case of Idiopathic Desquamative Interstitial Pneumonia Associated With IgA Glomerulonephritis in a 13-Month-Old Child.

Authors:  Simona Gurzu; Catalin Bogdan Satala; Lorena Elena Melit; Adrian Streinu-Cercel; Dan Otelea; Brandusa Capalna; Claudiu Ioan Puiac; Janos Szederjesi; Ioan Jung
Journal:  Front Pediatr       Date:  2020-11-11       Impact factor: 3.418

6.  A disorder of surfactant metabolism without identified genetic mutations.

Authors:  Silvia Montella; Timothy J Vece; Claire Langston; Paola Carrera; Lawrence M Nogee; Aaron Hamvas; Angelo Manna; Mariarosaria Cervasio; Mara Cervasio; Francesca Santamaria
Journal:  Ital J Pediatr       Date:  2015-11-25       Impact factor: 2.638

7.  Bronchoalveolar lavage fluid cytokine profiles in neuroendocrine cell hyperplasia of infancy and follicular bronchiolitis.

Authors:  Jonathan Popler; Brandie D Wagner; Heidi Luckey Tarro; Frank J Accurso; Robin R Deterding
Journal:  Orphanet J Rare Dis       Date:  2013-11-11       Impact factor: 4.123

Review 8.  Childhood rare lung disease in the 21st century: "-omics" technology advances accelerating discovery.

Authors:  Timothy J Vece; Jennifer A Wambach; James S Hagood
Journal:  Pediatr Pulmonol       Date:  2020-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.